"Pancreatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Descriptor ID |
D010190
|
| MeSH Number(s) |
C04.588.274.761 C04.588.322.475 C06.301.761 C06.689.667 C19.344.421
|
| Concept/Terms |
Pancreatic Neoplasms- Pancreatic Neoplasms
- Neoplasm, Pancreatic
- Pancreatic Neoplasm
- Pancreas Neoplasms
- Neoplasm, Pancreas
- Neoplasms, Pancreas
- Pancreas Neoplasm
- Neoplasms, Pancreatic
Cancer of Pancreas- Cancer of Pancreas
- Pancreas Cancers
- Pancreas Cancer
- Cancer, Pancreas
- Cancers, Pancreas
- Pancreatic Cancer
- Cancer, Pancreatic
- Cancers, Pancreatic
- Pancreatic Cancers
- Cancer of the Pancreas
|
Below are MeSH descriptors whose meaning is more general than "Pancreatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pancreatic Neoplasms".
This graph shows the total number of publications written about "Pancreatic Neoplasms" by people in this website by year, and whether "Pancreatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 0 | 3 |
| 1998 | 7 | 1 | 8 |
| 1999 | 2 | 0 | 2 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 3 | 1 | 4 |
| 2003 | 3 | 1 | 4 |
| 2004 | 5 | 0 | 5 |
| 2005 | 17 | 0 | 17 |
| 2006 | 10 | 2 | 12 |
| 2007 | 13 | 2 | 15 |
| 2008 | 13 | 2 | 15 |
| 2009 | 22 | 2 | 24 |
| 2010 | 16 | 4 | 20 |
| 2011 | 25 | 4 | 29 |
| 2012 | 16 | 2 | 18 |
| 2013 | 20 | 1 | 21 |
| 2014 | 14 | 3 | 17 |
| 2015 | 12 | 0 | 12 |
| 2016 | 19 | 2 | 21 |
| 2017 | 20 | 2 | 22 |
| 2018 | 24 | 4 | 28 |
| 2019 | 26 | 2 | 28 |
| 2020 | 23 | 0 | 23 |
| 2021 | 23 | 0 | 23 |
| 2022 | 17 | 1 | 18 |
| 2023 | 23 | 1 | 24 |
| 2024 | 11 | 3 | 14 |
| 2025 | 21 | 0 | 21 |
| 2026 | 8 | 0 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pancreatic Neoplasms" by people in Profiles.
-
Presentation, Management, and Outcomes of Cyst-Associated Pancreatic Cancer Versus Classic Pancreatic Ductal Adenocarcinoma. Pancreas. 2026 07 01; 55(6):e640-e646.
-
Alprazolam Reduces Inflammatory Cytokine Production in Pancreatic Cancer-Associated Fibroblasts. Cancer Res Commun. 2026 May 01; 6(5):1048-1060.
-
Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions. JAMA Netw Open. 2026 May 01; 9(5):e2613808.
-
Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups. BMC Cancer. 2026 Apr 21; 26(1).
-
A digital quality measure for emergency presentation of pancreatic cancer. Br J Cancer. 2026 Apr; 134(8):1209-1217.
-
Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth. Mol Cancer Ther. 2026 Feb 04; 25(2):257-271.
-
Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenocarcinoma. Sci Rep. 2026 Jan 07; 16(1):658.
-
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial. Nat Med. 2026 01; 32(1):258-269.
-
Diagnostic yield of endoscopic ultrasound-guided fine-needle biopsy of solid pancreatic lesions with tissue sent directly in formalin for histopathologic evaluation compared with cytology: a multicenter prospective pilot study. Gastrointest Endosc. 2026 07; 104(1):107-110.
-
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer. Cancer Res. 2025 Dec 01; 85(23):4825-4838.